| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2018 | ADJUVANCE TECHNOLOGIES INC. | 1225 L ST STE 600 | LINCOLN | NE | 68508-2139 | LANCASTER | USA | R44AI114030 | Large Scale Synthesis of the Next Generation Synthetic Saponin Adjuvant TiterQuil | 000 | 3 | NIH | 10/19/2020 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $743,432 ) |
| | 2018 | 2018 | ADJUVANCE TECHNOLOGIES INC. | 16 W 22ND ST, SIXTH FLOOR | NEW YORK | NY | 10010-5803 | NEW YORK | USA | R44AI114030 | Large Scale Synthesis of the Next Generation Synthetic Saponin Adjuvant TiterQuil | 000 | 3 | NIH | 2/15/2018 | $743,432 |
|
| Issue Date FY: 2017 ( Subtotal = $756,567 ) |
| | 2017 | 2017 | ADJUVANCE TECHNOLOGIES INC. | 16 W 22ND ST, SIXTH FLOOR | NEW YORK | NY | 10010-5803 | NEW YORK | USA | R44AI114030 | Large Scale Synthesis of the Next Generation Synthetic Saponin Adjuvant TiterQuil | 000 | 2 | NIH | 2/24/2017 | $756,567 |
|
| Issue Date FY: 2014 ( Subtotal = $225,000 ) |
| | 2014 | 2014 | ADJUVANCE TECHNOLOGIES INC | 116 WEST 22ND STREET | NEW YORK | NY | 10011 | NEW YORK | USA | R43AI114030 | Large Scale Synthesis of the Next Generation Synthetic Saponin Adjuvant TiterQuil | 000 | 1 | NIH | 6/6/2014 | $225,000 |
|
|
